Basal Cell Carcinoma-A Retrospective Descriptive Study Integrated in Current Literature

Basal cell carcinoma (BCC) is considered to be the most common cancer in humans. It has a slow growth rhythm, and for this reason, metastases are rare. For our retrospective study, we selected 180 patients from those who underwent surgery for a variety of skin tumours between January 2019 and August 2022 and whose histopathological examination revealed basal cell carcinoma. All surgeries were performed by plastic surgeons at the St. John hospital in Bucharest. The aim of this article is to provide observational data regarding BCC-in terms of histopathology and diagnostic and therapeutic management and to integrate these data into the current knowledge of this pathology.

Automated summary

Basal cell carcinoma (BCC) is the most common cancer in humans characterized by slow growth and rare metastases. A retrospective study was conducted on 180 patients who underwent surgery for various skin tumors between January 2019 and August 2022, and histopathological examination confirmed the presence of BCC. The study aimed to provide observational data on BCC, including histopathology, diagnostic, and therapeutic management, and integrate this information into current knowledge of the pathology.